triptans

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

102 competitors in Migraine

#DrugCompanyPhaseTrials

1

Zonegran

AAzurity Pharmaceuticals

Phase 3

32

Effient

CCosette Pharmaceuticals, Inc.

Phase 3

13

Magnesium

SSpherium Biomed

Phase 3

34

Aspirin /d

TThe First Affiliated Hospital with Nanjing Medical University

Phase 3

15

triptans

Pfizer

Phase 3

26

Flunarizine

AAspartes Pharmaceuticals, Inc.

Phase 3

97

BAT7104

Teva

Phase 3

18

Tizanidine Hydrochloride

EElan Pharmaceuticals

Phase 3

19

Bayer Aspirin

Bayer

Preclinical

210

Cervidil

Pfizer

Preclinical

1Show 29 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Migraine2 trials

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Active, not recruiting·GGuangdong Provincial People's Hospital·Phase 3·NCT04946734·440 enrolled

Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine

Completed·EEuropean Institute for Evidence Based Osteopathic Medicine·N/A·NCT01851148·105 enrolled

Outcome1 trial

Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

Completed·Pfizer··NCT06680206·1,395 enrolled

Headache1 trial

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Recruiting·—·Phase 4·NCT07022496·120 enrolled

Details

Drug Info

Related News